General Information of Drug (ID: DM9MKTJ)

Drug Name
Tcelna
Indication
Disease Entry ICD 11 Status REF
Multiple sclerosis 8A40 Phase 2 [1]
Cross-matching ID
TTD ID
D04JAB

References

1 ClinicalTrials.gov (NCT01684761) Study of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple Sclerosis. U.S. National Institutes of Health.